98%
921
2 minutes
20
Purpose: To describe a new retinal phenotype characterized by bilateral, multifocal, subretinal vitelliform lesions along the vascular arcades that we refer to as multifocal vitelliform paravascular retinopathy (MVPR).
Design: Observational case series.
Methods: Multimodal retinal imaging including color fundus photography, fundus autofluorescence and cross sectional and en-face optical coherence tomography was performed to evaluate and characterize the lesions of MVPR.
Results: Thirteen asymptomatic patients aged 10 to 78 [mean 49 ± 24, 49% under 50] were evaluated for bilateral retinal lesions. Initial visual acuity was 20/30 or better in 22 (85%) eyes. Of the 20 eyes with follow-up, 14 (70%) exhibited visual acuity 20/30 or better at final follow-up. Multifocal small round yellow lesions with distinct borders were identified along the vascular arcades in all patients. The vitelliform lesions were brightly hyperautofluorescent and consisted of focal areas of subretinal hyperreflective material on optical coherence tomography (OCT) that in some cases evolved to hyporeflective spaces (or retinal pigment epithelium atrophy) with associated hypoautofluorescence. When performed, electroretinography (ERG) and electrooculography (EOG) testing were normal and genetic testing was negative for variants in BEST1 and other genes associated with vitelliform retinopathies.
Conclusions: MVPR may represent a novel entity of vitelliform disorders with a distinct clinical presentation and phenotype and generally favorable prognosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ajo.2024.08.028 | DOI Listing |
Retin Cases Brief Rep
July 2025
Department of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel.
Purpose: Idiopathic acute exudative polymorphous vitelliform maculopathy (AEPVM) is a rare condition characterized by acute vision loss and distinctive retinal findings. Here we describe the disease course in three previously unpublished subjects diagnosed with AEPVM and a previously undescribed imaging feature.
Methods: We present the clinical presentation, disease progression, and multimodal imaging, along with retinal electrophysiology and genetic testing for PRPH2 and BEST1.
Retin Cases Brief Rep
April 2025
Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania Philadelphia, PA, USA.
Purpose: To describe the clinical and multimodal imaging findings of two siblings with different vitelliform phenotypes associated with a novel IMPG1 gene deletion.
Methods: Case series of two siblings. Patients underwent standard optical coherence tomography (OCT), fundus color and short-wavelength fundus autofluorescence (SW-FAF) imaging, fluorescein angiography, and genetic testing for a panel of inherited retinal disorders.
Retina
April 2025
Retinal Disorders and Ophthalmic Genetics Division, Stein Eye Institute, University of California of Los Angeles, David Geffen School of Medicine at UCLA, Los Angeles, California, United States.
Purpose: To describe the clinical and multimodal imaging features, and long-term outcomes, of acquired vitelliform lesions (AVLs) in angioid streaks (AS).
Methods: Retrospective case series including 14 patients (23 eyes) with AS-related AVLs. Clinical data, color fundus photography, fundus autofluorescence, spectral-domain optical coherence tomography (OCT), en face OCT, and OCT angiography were evaluated at baseline and final visits.
Am J Ophthalmol
July 2025
Stein Eye Institute, University of California Los Angeles, Los Angeles, California, USA; Greater Los Angeles VA Healthcare Center, Los Angeles, California, USA. Electronic address:
Am J Ophthalmol
July 2025
Amsterdam University Medical Center, Amsterdam, the Netherlands; Leiden University Medical Center, Leiden, the Netherlands.